Role of the Cyclosporin-sensitive Transcription Factor NFAT1 in the Allergic Response

Memorias do Instituto Oswaldo Cruz

Volumn 92 SUPPL. 2, Issue , 1997, Pages 147-155

  Viola, João P B ^a   Rao, Anjana ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cyclosporin; Interleukin; Nuclear factor of activated T cells

Indexed keywords

CYCLOSPORIN DERIVATIVE; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 10; TRANSCRIPTION FACTOR;

ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; IN VITRO STUDY; MAST CELL; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; CYCLOSPORINS; CYTOKINES; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INTERLEUKIN-10; MAST CELLS; MICE; TRANSCRIPTION FACTORS;

EID: 18844464227     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000800020     Document Type: Article

References (99)

1. Aramburu J, Azzoni L, Rao A, Perussia B 1995. Activation and expression of the nuclear factor of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD 16 ligand binding. J Exp Med 182: 801-810.
2. Bochner BS, Klunk DA, Sterbinsky SA, Coffman RL, Schleimer RP 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154: 799-803.
3. Boss V, Talpade DJ, Murphy TJ 1996. Induction of NFAT-mediated transcription by Gq-coupled receptors in lymphoid and non-lymphoid cells. J Biol Chem 271: 10429-10432.
4. Brabletz T, Pietrowski I, Serfling E 1991. The immunosuppressives FK506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer. Nucleic Acids Res 19: 61-67.
5. Bradley BL, Azzawi M, Jacobson M, Assoufi B, Collins JV, Irani AMA, Schwartz LB, Durham SR, Jeffrey PK, Kay AB 1991. Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy speciments from atopic subjects without asthma and control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 88: 661-670.
6. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman LB, Schwartz LB, Wasserman SI 1991. Evidence of ongoing mast cells and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 88: 637-648.
7. Broide DH, Paine MM, Firestein GS 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90: 1414-1424.
8. Brown DA, Nelson FB, Reinherz EL, Diamond DJ 1991. The human interferon-γ gene contains an inducible promoter that can be transactivated by tax I and II. Eur J Immunol 21: 1879-1885.
9. Campbell PM, Pimm J, Ramassar V, Halloran PF 1996. Identification of a calcium-inducible, cyclosporine-sensitive element in the IFN-g promoter that is a potential NFAT binding site. Transplantation 61: 933-939.
10. Carter LL, Dutton RW 1996. Type 1 and type 2: a fundamental dichotomoy for all T-cell subsets. Curr Opin Immunol 8: 336-342.
11. Casolaro V, Georas SN, Song Z, Zubkoff ID, Abdulkadir SA, Thanos D, Ono SJ 1995. Inhibition of NF-AT-dependent transcription by NF-kB: implications for differential gene expression in T helper cell subsets. Proc Natl Acad Sci USA 92: 11623-11627.
12. Casolaro V, Georas SN, Song Z, Ono SJ 1996. Biology and genetics of atopic disease. Curr Opin Immunol 8: 796-803.
13. Chen L, Oakley MG, Glover JNM, Jain J, Dervan PB, Hogan PG, Rao A, Verdine GL 1995. Only one of the two DNA-bound orientations of AP-1 found in solution cooperates with NFATp. Current Biology 5: 882-889.
14. Choi MSK, Brines RD, Holman MJ, Klaus GGB 1994. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1: 179-187.
15. Chytil M, Verdine GL 1996. The Rel family of eukaryotic transcription factors. Curr Opin Struct Biol 6: 91-100.
16. Clutterbuck EJ, Sanderson CJ 1988. Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differntiation factor (IL-5): production of functionally active eosinophils from normal human bone marrow. Blood 71: 646-651.
17. Cockerill GW, Bert AG, Ryan GR, Gamble JR, Vadas MA, Cockerill PN 1995a. Regulation of granulocyte-macrophage colony-stimulating factor and E-selectin expression in endothelial cells by cyclosporin A and the T-cell transcription factor NFAT. Blood 86: 2689-2698.
18. Cockerill PN, Bert AG, Jenkins F, Ryan GR, Shannon MF, Vadas MA 1995b. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol Cell Biol 15: 2071-2079.
19. Coffier E, Joseph D, Vergaftig BB 1991. Activation of guinea pig eosinophils by human reconbinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists. J Immunol 147: 2595-2602.
20. Crabtree GR 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243: 355-361.
21. Crabtree GR, Clipstone NA 1994. Signal transmission between the plasma membrane and nucleus of T-lymphocytes. Annu Rev Biochem 63: 1045-1083.
22. Dent LA, Strath M, Mellor AL, Sanderson CJ 1990. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172: 1425-1431.
23. Desai DM, Newton ME, Kadlecek T, Weiss A 1990. Stimulation of the phosphatidylinositol pathway can induce T-cell activation. Nature 348: 66-69.
24. Desreumaux P, Bloget F, Seguy D, Capron M, Cortot A, Colombel JF, Janin A 1996. Interlukin-3, granulocyte macrophage-colony stimulating factor and interleukin-5 synthesis in eosinophilic gastroenteritis. Gastroenterology 110: 768-774.
25. Desreumaux P, Capron M 1996. Eosinophils in alergic reactions. Curr Opin Immunol 8: 790-795.
26. Drazen JM, Arm JP, Austen KF 1996. Sorting out the cytokines of asthma. J Exp Med 183: 1-5.
27. Dolganov G, Bort S, Lovett M, Burr J, Schubert L, Short D, McGurn M, Gibson C, Lewis DB 1996. Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 87:3316-3326.
28. 2+ response amplitude and duration. Nature 386: 855-858.
29. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG 1995. IL-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201.
30. Gonzalo JA, Jia GQ, Aguirre V, Friend D, Coyle AJ, Jenkins NA, Lin GS, Katz H, Lichtman A, Copeland N, Kopf M, Gutierrez-Ramos JC 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but not restricted to a Th2-type response. Immunity 4: 1-14.
31. Ho AM, Jain J. Rao A, Hogan PG 1994. Expression of the transcription factor NFATp in a neuronal cell line and in the murine nervous system. J Biol Chem 269: 28181-28186.
32. Ho SN, Thomas DJ, Timmerman LA, Li X, Francke U, Crabtree GR 1995. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity. J Biol Chem 270: 19898-19907.
33. Hodge MR, Ranger AM, de la Brousse FC, Hoey T, Grusby M, Glimcher LH 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4: 397-405.
34. Hoey T, Sun Y-L, Williamson K, Xu X 1995. Isolation of two new members of the NFAT gene family and functional characterization of the NFAT proteins. Immunity 4: 461-472.
35. Hutchinson LE, McCloskey MA 1995. FceRI-mediated induction of nuclear factor of activated T-cells. J Biol Chem 270: 16333-16338.
36. Jain J, Miner Z, Rao A 1993a. Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J Immunol 151: 837-848.
37. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A 1993b. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365: 352-355.
38. Jain J, Burgeon E, Badalian TM, Hogan PG, Rao A 1995a. A similar DNA-binding motif in NFAT family proteins and the Rel homology region. J Biol Chem 270: 4138-4145.
39. Jain J, Loh C, Rao A 1995b. Transcriptional regulation of the interleukin 2 gene. Curr Opin Immunol 7: 333-342.
40. Jia GQ, Gonzalo JA, Lloyd C, Kremer L, Lu L, Martinez C, Wershil BK, Gutierrez-Ramos JC 1996. Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation. J Exp Med 184: 1939-1951.
41. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in guinea-pig model of allergic airways inflammation. J Exp Med 179: 881-887.
42. Kelly K, Siebenlist U. 1995. Immediate-early genes induced by antigen receptor stimulation. Curr Opin Immunol 7: 327-332.
43. Kita H and Gleich GJ. 1996. Chemokines active on eosinophils - potentials roles in allergic inflammation. J Exp Med 183: 2421-2426.
44. Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milbourne EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI 1996. IL-5-deficient mice have a development defect in CDS B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell response. Immunity 4: 15-24.
45. Leonard DG, Ziff EB, Greene LA 1987. Identification and characterization of mRNAs regulated by nerve growth factor in PC 12 cells. Mol Cell Biol 7: 3156-3167.
46. Loh C, Shaw KTY, Carew J, Viola JPB, Luo C, Perrino BA, Rao A 1996a. Calcineurin binds the transcription factor NFAT1 and reversibly regulates its activity. J Biol Chem 271: 10884-10891.
47. Loh C, Carew JA, Kim J, Hogan PG, Rao A 1996b. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol Cell Biol 16: 3945-3954.
48. Luo C, Burgeon E, Carew JA, Badalian TM, McCaffrey PG, Lane WS, Hogan PG, Rao A 1996. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates the transcription of several cytokine genes. Mol Cell Biol 16: 3955-3966.
49. Lopez AF, Begley CG, Williamson DJ, Warren DJ, Vadas MA, Sanderson CJ 1986. Murine eosinophils differentiation factor: an eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med 163: 1085-1099.
50. Mattila PS, Ullman KS, Fiering S, Emmel EA, McCutcheon M, Crabtree GR, Herzenberg LA 1990. The action of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J 9: 4425-4433.
51. Masuda E, Naito Y, Tokumitsu H, Campbell D, Saito F, Hannum C, Arai K-I, Arai N 1995. NFATx, a novel member of the NFAT family that is expressed predominantly in the thymus. Mol Cell Biol 15: 2697-2706.
52. McCaffrey PG, Luo C, Kerppola TK, Jain J, Badalian TM, Ho AM, Burgeon E, Lane WS, Lambert JN, Curran T, Verdine GL, Rao A, Hogan PG 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262: 750-754.
53. McCaffrey PG, Goldfeld AE, Rao A 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-a gene transcription. J Biol Chem 269: 30445-30450.
54. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I 1994. Role of vascular cell adhesion molecule 1/ very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated 1 interactions in antigen-induced eosinophil and T cell recruitment in the tissue. J Exp Med 179: 1145-1154.
55. Nolan GP 1994. NF-AT-AP-1, Rel-bZIP: hybrid vigor and binding under the influence. Cell 77: 795-798.
56. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497-502.
57. Pare PD, Bai TR 1995. The consequences of chronic allergic inflammation. Thorax 50: 328-332.
58. Park J, Takeuchi A, Sharma S 1996. Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc. J Biol Chem 34: 29014-29021.
59. Paul WE, Seder RA 1994. Lymphocyte responses and cytokines. Cell 76: 241-251.
60. Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, Wang Y, Walunas T, Bluestone J, Listman J, Finn PW 1996. Regulation of CTLA-4 expression during T cell activation. J Immnnol 156: 4154-4159.
61. Peters SP 1990. Mast cells and histamine in asthma. J Allergy Clin Immunol 86: 642-646.
62. Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wuang J, Kassam N, Smith H, Shi X, Gonzalo JA, Newman W et al. 1996. Cloning of the human eosinophil chemoattractant eotaxin. J Clin Invest 97: 604-612.
63. Pretolani M, Ruffle C, Silva JRD, Joseph D, Lobb RR, Vergaftig BB 1994. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 180: 795-805.
64. Prieschl EE, Gouilleux-Gruart V, Walker C, Harrer NE, Baumruker T 1995a. A nuclear factor of activated T cell-like transcription factor in mast cells is involved in IL-5 gene regulation after IgE plus antigen stimulation. J Immunol 154: 6112-6119.
65. Prieschl EE, Pendl GG, Harrer NE, Baumruker T 1995b. p21ras links FceRI to NF-AT family member in mast cells: the AP3-like factor in this cell type is an NFAT family member. J Immunol 155: 4963-4970.
66. Randak C, Brabletz T, Hergenröther M, Sobotta I, Serfling E 1990. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. EMBO J 9: 2529-2536.
67. Rao A 1994. NF-ATp: a transcription factor required for the coordinate induction of several cytokine genes. Immunol. Today 15: 274-281.
68. Rao A, Luo C, Hogan PG 1997. Transcription factors of the NFAT family: regulation and function. Ann Rev Immunol 15: 707-747.
69. Romagnani S 1995. Technological advances and new insights into pathogenesis prelude novel therapeutic strategies. Curr Opin Immunol 7: 745-750.
70. Rooney JW, Sun Y-L, Glimcher LH, Hoey T 1995a. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol 15: 6299-6310.
71. Rooney JW, Hoey T, Glimcher LH 1995b. Coordinate and cooperative roles for NFAT and AP-1 in the regulation of the murine IL-4 gene. Immunity 2: 473-483.
72. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P 1997. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 185: 785-790.
73. Ruff VA, Leach KL 1995. Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J Biol Chem 260: 22602-22607.
74. Sanderson CJ, Warren DG, Strath M 1985. Identification of a lymphokine that stimulates eosinophil diffrentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med 162: 60-74.
75. Sarafi MN, Garcia-Zepeta EA, MacLean JA, Charo IF, Luster AD 1997. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 185: 99-109.
76. Schubert LA, King G, Cron RQ, Lewis DB, Aruffo A, Hollenbaugh D 1995. The human gp39 promoter. J Biol Chem 270: 29624-29627.
77. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB 1992. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79: 2952-2959.
78. Serfling E, Avots A, Neumann M 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochem Biophys Acta 1263: 181-200.
79. Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR 1988. Identification of a putative regulator of early T cell activation genes. Science 241: 202-205.
80. Shaw KTY, Ho AM, Raghavan A, Kim J, Jain J, Park J, Sharma S, Rao A, Hogan PG 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of the transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci USA 92: 11205-11209.
81. Sullivan S, Broide DH 1996. Compartimentalization of eosinophil granulocyte-macrophage colony-stimulating factor expression in patients with asthma. J Allergy Clin Immunol 97: 966-976.
82. Takatsu K, Tominaga A, Harada N, Mita S, Matsumoto M, Takahashi T, Kikuchi Y, Yamaguchi N 1988. T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev 102: 107-135.
83. Tsai EY, Jain J, Pesavento PA, Rao A, Goldfeld AE 1996. Tumor necrosis factor alpha gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol 16: 459-467.
84. Tsytsykova AV, Tsitsikov EN, Geha RS. 1996 The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem 271: 3763-3770.
85. Ullman KS, Flanagan WM, Edwards CA, Crabtree GR 1991. Activation of early gene expression in T lymphocytes by Oct-1 and an inducible protein, OAP40. Science 254: 558-562.
86. Venkataraman L, Francis DA, Wang Z, Liu J, Rothstein TL, Sen R 1994. Cyclosporin A-sensitive induction of NF-AT in murine B cells. Immunity 1: 189-196.
87. Wagner C, Gundel R, Reily P, Haynes N, Letts L, Rothlein R 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247: 456-459.
88. Wang DZ, McCaffrey PG, Rao A 1995. The cyclosporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system. Ann N Y Acad Sci 766: 182-194.
89. Wardlaw AJ, Symon FS, Walsh GM 1994. Eosinophil adhesion in allergic inflammation. J Allergy Clin Immunol 94: 1163-1171.
90. Warren DJ, Moore MAS 1988. Synergism among interleukin 1, interleukin 3 and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. J Immunol 140: 94-99.
91. Warringa RAJ, Mengelers HJJ, Kuijper PHM, Raaijmakers JAM, Bruijnzeel PBL, Koenderman L 1992. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals. Blood 79: 1836-1841.
92. Weiss A, Littman DR 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.
93. Weiss DL, Hural J, Tara D, Timmerman LA, Henkel G, Brown MA 1996. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol Cell Biol 16: 228-235.
94. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RJ 1991. Human eosinophil adherence to vascular endothelium mediated by binding VCAM-1 and ELAM-1. Proc Natl Acad Sci USA 88: 7430-7435.
95. Weller PF 1993. Lipid, peptide and cytokine mediators elaborated by eosinophils, p. 25-42. In H Smith, RM Cook (eds.), Immunopharmacology of Eosinophils. Academic Press Incorporated, London.
96. Wu J, Katzav S, Weiss A 1995. A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol 15: 4337-4346.
97. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167: 43-56.
98. Yaseen KR, Maizel AL, Wang F, Sharma S 1993. Comparative analysis of NFAT (nuclear factor of activated T cells) complex in human T and B lymphocytes. J Biol Chem 268: 14285-14293.
99. Xanthoudakis S, Viola JPB, Shaw KTY, Luo C, Wallace JD, Bozza PT, Curran T, Rao A 1996. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272: 892-895.